Protocol of Kohan et al for High Dose Intravenous Immunoglobulin (IVIG) to Prevent Hemolysis Following a Non-ABO Incompatible Blood Transfusion


Allergy, Immunology, Anesthesiology, Cardiology, Dermatology, Endocrinology, Diabetes, Metabolism, Emergency Medicine, Family, General Practice, Geriatrics, Internal Medicine, Medical Genetics, Neurological Surgery, Neurology, Obstetrics, Gynecology, Oncology, Ophthalmology, Orthopedics, Otolaryngology, Pathology, Pediatrics, Physical Medicine and Rehabilitation, Plastic Surgery, Preventive Medicine, Psychiatry, Radiology, Surgery, Urology, Other




Kohan et al developed a protocol for administration of high dose intravenous immunoglobulin (IVIG) in a patient who has received a transfusion of non-ABO incompatible blood. This can help reduce hemolysis following the transfusion and allow the patient to undergo lifesaving therapy. The authors are from Hospital de Clinicas "Jose de San Martin" and the Universidad de Buenos Aires in Argentina.

To read more or access our algorithms and calculators, please log in or register.


medal descover
medal iphone